Discovery of a genetic metabolic cause for mauriac syndrome in type 1 diabetes

Diabetes

Volumn 65, Issue 7, 2016, Pages 2051-2059

  MacDonald, Michael J ^a   Hasan, Noaman M ^a   Ansari, Israr Ul H ^a   Longacre, Melissa J ^a   Kendrick, Mindy A ^a   Stoker, Scott W ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOGEN PHOSPHORYLASE; GLYCOGEN; PHOSPHORYLASE KINASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE MUTATION; GLUCOSE BLOOD LEVEL; GLYCOGEN METABOLISM; GLYCOGENOLYSIS; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MAURIAC SYNDROME; PRIORITY JOURNAL; ADOLESCENT; CASE REPORT; DELAYED PUBERTY; GENETICS; GROWTH DISORDER; HEPATOMEGALY; MALE; METABOLISM; MUTATION; SYNDROME;

ADOLESCENT; DIABETES MELLITUS, TYPE 1; GLYCOGEN; GLYCOGEN PHOSPHORYLASE, LIVER FORM; GROWTH DISORDERS; HEPATOMEGALY; HUMANS; MALE; MUTATION; PHOSPHORYLASE KINASE; PUBERTY, DELAYED; SYNDROME;

EID: 84975889705     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db16-0099     Document Type: Article

References (33)

1. Mauriac P. Gros ventre, hepatomegalie, troubles de croissance chez les enfants diabetiques traites depuis plusiers annee par l'insuline. Gaz Hebd Med Bordeaux 1930;26:402-410
2. Hasan NM, Kendrick MA, Druckenbrod NR, Huelsmeyer MK, Warner TF, MacDonald MJ. Genetic association of the neuropilin-1 gene with type 1 diabetes in children: neuropilin-1 expression in pancreatic islets. Diabetes Res Clin Pract 2010;87:e29-e32
3. Brown LJ, Longacre MJ, Hasan NM, Kendrick MA, Stoker SW, Macdonald MJ. Chronic reduction of the cytosolic or mitochondrial NAD(P)-malic enzyme does not affect insulin secretion in a rat insulinoma cell line. J Biol Chem 2009; 284:35359-35367
4. MacDonald MJ, Smith AD 3rd, Hasan NM, Sabat G, Fahien LA. Feasibility of pathways for transfer of acyl groups from mitochondria to the cytosol to form short chain acyl-CoAs in the pancreatic beta cell. J Biol Chem 2007;282:30596-30606
5. MacDonald MJ, Longacre MJ, Stoker SW, et al. Differences between human and rodent pancreatic islets: low pyruvate carboxylase, ATP citrate lyase, and pyruvate carboxylation and high glucose-stimulated acetoacetate in human pancreatic islets. J Biol Chem 2011;286:18383-18396
6. Hasan NM, Longacre MJ, Stoker SW, et al. Impaired anaplerosis and insulin secretion in insulinoma cells caused by small interfering RNA-mediated suppression of pyruvate carboxylase. J Biol Chem 2008;283:28048-28059
7. Fernandes F, Ansari IU, Striker R. Cyclosporine inhibits a direct interaction between cyclophilins and hepatitis C NS5A. PLoS One 2010;5:e9815
8. Passonneau JV, Lauderdale VR. A comparison of three methods of glycogen measurement in tissues. Anal Biochem 1974;60:405-412
9. Passonneau JV, Lowry OH. A collection of metabolite assays, glycogen. In Enzymatic Analysis: A Practical Guide. Passonneau JV, Lowry OH, Eds. Totowa, NJ, Humana Press, 1993, p. 177-179
10. Hers HG The control of glycogen metabolism in the liver. Annu Rev Biochem 1976;45:167-189
11. Davit-Spraul A, Piraud M, Dobbelaere D, et al. Liver glycogen storage diseases due to phosphorylase system deficiencies: diagnosis thanks to non invasive blood enzymatic and molecular studies. Mol Genet Metab 2011;104:137-143
12. Bollen M, Keppens S, Stalmans W. Specific features of glycogen metabolism in the liver. Biochem J 1998;336:19-31
13. Goldstein JL, Austin SL, Boyette K, et al. Molecular analysis of the AGL gene: identification of 25 novel mutations and evidence of genetic heterogeneity in patients with glycogen storage disease type III. Genet Med 2010;12:424-430
14. Chou JY, Jun HS, Mansfield BC. Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy. Nat Rev Endocrinol 2010;6:676-688
15. Cheung YY, Kim SY, Yiu WH, et al. Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta. J Clin Invest 2007;117:784-793
16. Boztug K, Appaswamy G, Ashikov A, et al. A syndrome with congenital neutropenia and mutations in G6PC3. N Engl J Med 2009;360:32-43
17. Beauchamp NJ, Dalton A, Ramaswami U, et al. Glycogen storage disease type IX: high variability in clinical phenotype. Mol Genet Metab 2007;92: 88-99
18. Burwinkel B, Maichele AJ, Aagenaes O, et al. Autosomal glycogenosis of liver and muscle due to phosphorylase kinase deficiency is caused by mutations in the phosphorylase kinase beta subunit (PHKB). Hum Mol Genet 1997;6:1109-1115
19. Burwinkel B, Amat L, Gray RG, et al. Variability of biochemical and clinical phenotype in X-linked liver glycogenosis with mutations in the phosphorylase kinase PHKA2 gene. Hum Genet 1998;102:423-429
20. Burwinkel B, Rootwelt T, Kvittingen EA, Chakraborty PK, Kilimann MW. Severe phenotype of phosphorylase kinase-deficient liver glycogenosis with mutations in the PHKG2 gene. Pediatr Res 2003;54:834-839
21. Bali DS, Goldstein JL, Fredrickson K, et al. Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene. Mol Genet Metab 2014;111:309-313
22. Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet 2013;Chapter 7: Unit7.20
23. Nadeau OW, Lane LA, Xu D, et al. Structure and location of the regulatory β subunits in the (αβγδ)4 phosphorylase kinase complex. J Biol Chem 2012;287: 36651-36661
24. Vénien-Bryan C, Lowe EM, Boisset N, Traxler KW, Johnson LN, Carlson GM. Three-dimensional structure of phosphorylase kinase at 22 A resolution and its complex with glycogen phosphorylase b. Structure 2002;10:33-41
25. Munns CF, McCrossin RB, Thomsett MJ, Batch J. Hepatic glycogenosis: reversible hepatomegaly in type 1 diabetes. J Paediatr Child Health 2000;36:449-452
26. Hudacko RM, Manoukian AV, Schneider SH, Fyfe B. Clinical resolution of glycogenic hepatopathy following improved glycemic control. J Diabetes Complications 2008;22:329-330
27. Saadi T. Glycogenic hepatopathy: a rare disease that can appear and resolve rapidly in parallel with glycemic control. Isr Med Assoc J 2012;14:269-270
28. Torbenson M, Chen YY, Brunt E, et al. Glycogenic hepatopathy: an under-recognized hepatic complication of diabetes mellitus. Am J Surg Pathol 2006;30: 508-513
29. El-Karaksy HM, Anwar G, Esmat G, et al. Prevalence of hepatic abnormalities in a cohort of Egyptian children with type 1 diabetes mellitus. Pediatr Diabetes 2010;11:462-470
30. Nelson DL, Cox MM, Lehninger AL. Lehninger Principles of Biochemistry. 3rd ed. New York, Worth Publishers, 2000, p. 557
31. Stalmans W, Bollen M, Mvumbi L. Control of glycogen synthesis in health and disease. Diabetes Metab Rev 1987;3:127-161
32. Roach PJ Glycogen and its metabolism. Curr Mol Med 2002;2:101-120
33. Stalmans W, Laloux M, Hers HG. The interaction of liver phosphorylase a with glucose and AMP. Eur J Biochem 1974;49:415-427